Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 38c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $43.15 +1.63%
EPS Growth %: -35.0%
Financial Fact:
Service revenues: 3.57M
Today's EPS Names:
DTGI, OCCI, MAYS, More
EPS Growth %: -35.0%
Financial Fact:
Service revenues: 3.57M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($1.20), $0.38 worse than the analyst estimate of ($0.82).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- InterContinental Hotels Group (IHG:LN) (IHG) PT Raised to $190 at Goldman Sachs
- Contango settles $18.75M Lucky Shot obligations for $6.57M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
